GE HealthCare (GEHC) CEO receives new stock option and RSU grants

(Neutral)

Form Type

Rhea-AI Filing Summary

Arduini Peter J reported acquisition or exercise transactions in this Form 4 filing.

GE HealthCare Technologies Inc. reported that President and CEO Peter J. Arduini received new equity awards. He was granted an employee stock option covering 129,140 shares of GE HealthCare common stock and 49,120 restricted stock units, each representing one share of common stock at settlement.

According to the vesting schedule, 33% of both the restricted stock units and the stock options will vest or become exercisable on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029. Following the stock grant, Arduini directly owned 255,255 shares of common stock.

Insider Trade Summary

Net Buyer: 49,120 shares

Net Buy 2 txns

Insider Arduini Peter J

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	129,140	$0.00	--
Grant/Award	Common Stock, par value $0.01 per share	49,120	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 129,140 shares (Direct); Common Stock, par value $0.01 per share — 255,255 shares (Direct)

Footnotes (1)

Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/04/2026 - 04:22 PM

FAQ

What did GE HealthCare (GEHC) disclose about Peter Arduini in this Form 4?

The Form 4 shows CEO Peter J. Arduini received new equity awards. He was granted 129,140 employee stock options and 49,120 restricted stock units, all tied to GE HealthCare common stock, as part of his executive compensation package.

How many stock options did the GE HealthCare CEO receive in the latest filing?

Peter J. Arduini received an employee stock option for 129,140 shares. These options relate to GE HealthCare common stock and will become exercisable over time based on the disclosed vesting schedule through 2029, aligning his compensation with longer-term company performance.

What restricted stock unit (RSU) award was reported for GEHC CEO Peter Arduini?

The filing reports a grant of 49,120 restricted stock units to Peter J. Arduini. Each RSU represents the right to receive one share of GE HealthCare common stock at settlement, subject to time-based vesting over the 2027–2029 period.

What is the vesting schedule for Peter Arduini’s new GE HealthCare equity awards?

Both the restricted stock units and stock options vest on the same schedule. 33% vest or become exercisable on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029, encouraging multi-year retention.

How many GE HealthCare common shares does Peter Arduini own after these transactions?

After the reported grant of 49,120 shares of common stock underlying restricted stock units, Peter J. Arduini directly owned 255,255 shares of GE HealthCare common stock, according to the ownership figure disclosed in the Form 4 filing.

Were these GEHC insider transactions open-market purchases or awards?

The transactions are described as grants or awards, not open-market trades. Both the stock options and restricted stock units were acquired at a reported price of $0.00 per share, indicating compensation-related awards rather than market purchases or sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arduini Peter J

(Last)

(First)

(Middle)

500 W. MONROE STREET

(Street)

CHICAGO

60661

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	03/02/2026		A		49,120⁽¹⁾⁽²⁾	A	$0	255,255	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$80.16	03/02/2026		A		129,140		⁽³⁾	03/02/2036	Common Stock, par value $0.01 per share	129,140	$0⁽³⁾	129,140	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR